Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rumiko Okamoto

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2016
[Effectiveness of Dexrazoxane for Extravasation of Anthracycline Antitumor Antibiotics - Reporting Measures Developed against Extravasation in the Hospital]Satoshi Kawamoto, Takuya Shirahata, Tetsuya Katori, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 11, 2006
[The present state and future of home care for gastric cancer patients]Yoshiharu Maeda, Eisaku Sasaki, Michio Mikoshiba, et al.
Journal of Cardiothoracic Surgery|September 28, 2018
Treatment of malignant primary cardiac lymphoma with tumor resection using minimally invasive cardiac surgeryYuki Endo, Yoshitsugu Nakamura, Miho Kuroda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[A case of colon cancer with reversible posterior leukoencephalopathy syndrome following 5-FU and oxaliplatin (FOLFOX regime)]Yasunobu Nagata, Yasushi Omuro, Tatsu Shimoyama, et al.
Journal of Gastroenterology|September 27, 2012
Kinetics of peripheral hepatitis B virus-specific CD8+ T cells in patients with onset of viral reactivationJun Aoki, Yuka Kowazaki, Takahiro Ohtsuki, et al.
Cancer Science|January 22, 2013
Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trialsYasuo Ohashi, Yukari Uemura, Yasuhito Fujisaka, et al.
Oncotargets and Therapy|July 18, 2018
Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphomaJie Jin, Rumiko Okamoto, Sung-Soo Yoon, et al.
Haematologica|February 11, 2017
Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP <i>versus</i> R-CHOP in the phase 3 LYM-3002 studyGregor Verhoef, Tadeusz Robak, Huiqiang Huang, et al.
The Lancet. Oncology|October 24, 2018
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 studyTadeusz Robak, Jie Jin, Halyna Pylypenko, et al.
Leukemia & Lymphoma|June 7, 2017
Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study<sup>.</sup>Tadeusz Robak, Huiqiang Huang, Jie Jin, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2016
[Effectiveness of Dexrazoxane for Extravasation of Anthracycline Antitumor Antibiotics - Reporting Measures Developed against Extravasation in the Hospital]Satoshi Kawamoto, Takuya Shirahata, Tetsuya Katori, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 11, 2006
[The present state and future of home care for gastric cancer patients]Yoshiharu Maeda, Eisaku Sasaki, Michio Mikoshiba, et al.
Journal of Cardiothoracic Surgery|September 28, 2018
Treatment of malignant primary cardiac lymphoma with tumor resection using minimally invasive cardiac surgeryYuki Endo, Yoshitsugu Nakamura, Miho Kuroda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[A case of colon cancer with reversible posterior leukoencephalopathy syndrome following 5-FU and oxaliplatin (FOLFOX regime)]Yasunobu Nagata, Yasushi Omuro, Tatsu Shimoyama, et al.
Journal of Gastroenterology|September 27, 2012
Kinetics of peripheral hepatitis B virus-specific CD8+ T cells in patients with onset of viral reactivationJun Aoki, Yuka Kowazaki, Takahiro Ohtsuki, et al.
Cancer Science|January 22, 2013
Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trialsYasuo Ohashi, Yukari Uemura, Yasuhito Fujisaka, et al.
Oncotargets and Therapy|July 18, 2018
Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphomaJie Jin, Rumiko Okamoto, Sung-Soo Yoon, et al.
Haematologica|February 11, 2017
Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP <i>versus</i> R-CHOP in the phase 3 LYM-3002 studyGregor Verhoef, Tadeusz Robak, Huiqiang Huang, et al.
The Lancet. Oncology|October 24, 2018
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 studyTadeusz Robak, Jie Jin, Halyna Pylypenko, et al.
Leukemia & Lymphoma|June 7, 2017
Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study<sup>.</sup>Tadeusz Robak, Huiqiang Huang, Jie Jin, et al.
Pageof 3